Prognostic factors of carcinoma of the ampulla of Vater after surgery

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 1143-1148

  Zhou, Jianguo ^a   Zhang, Qian ^b   Li, Peng ^a   Shan, Yi ^a   Zhao, Dongbing ^a   Cai, Jianqiang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b Aero Space Center Hospital   (China)

Author keywords

Carcinoma of the ampulla of vater; Lymph nodemetastasis; Prognosis; Surgical treatment

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ABDOMINAL INFECTION; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA OF THE AMPULLA OF VATER; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGIC SHOCK; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JAUNDICE; LOCAL EXCISION; LUNG INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE DISTRIBUTION; RADICAL RESECTION; RETROSPECTIVE STUDY; SMALL INTESTINE CARCINOMA; STOMACH PARESIS; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; VATER PAPILLA;

ADULT; AGED; AMPULLA OF VATER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA; COMMON BILE DUCT NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 84899100925     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1153-9     Document Type: Article

References (31)

1. Neugut AI, Jacobson JS, Rella VA. Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. Gastrointest Endosc Clin N Am. 1997;7:387-99. (Pubitemid 27317341)
2. Barauskas G, Gulbinas A, Pranys D, et al. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008;15:423-8.
3. Al Ustwani O, Iancu D, Yacoub R, Iyer R. Detection of circulating tumor cells in cancers of biliary origin. J Gastrointest Oncol. 2012;3:97-104.
4. Pantel K, Alix-Panabières C. Detection methods of circulating tumor cells. J Thorac Dis. 2012;4:446-7.
5. O'Connell JB, Maggard MA, Manunga Jr J, et al. Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol. 2008;15:1820-7.
6. Yoon YS, Kim SW, Park SJ, et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg. 2005;242:92-100. (Pubitemid 40917972)
7. Shiba H, Misawa T, Fujiwara Y, et al. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater. Anticancer Res. 2013;33:2715-21.
8. Ma X, Zhang QY. Protein microarrays for quantitative detection of PAI-1 in serum. Chin J Cancer Res. 2012;24:220-5.
9. Ito K, Fujita N, Noda Y, et al. Diagnosis of ampullary cancer. Dig Surg. 2010;27:115-8.
10. Clary BM, Tyler DS, Dematos P, et al. Local ampullary resection with careful intraoperative frozen section evaluation for presumed benign ampullary neoplasms. Surgery. 2000;127:628-33. (Pubitemid 30399053)
11. Heinrich S, Clavien PA. Ampullary cancer. Curr Opin Gastroenterol. 2010;26:280-5.
12. Demetriades H, Zacharakis E, Kirou I, et al. Local excision as a treatment for tumors of ampulla of Vater. World J Surg Oncol. 2006;4:14.
13. Lee SY, Jang KT, Lee KT, et al. Can endoscopic resection be applied for early stage ampulla of Vater cancer? Gastrointest Endosc. 2006;63:783-8.
14. Yoon SM, Kim MH, Kim MJ, et al. Focal early stage cancer in ampullary adenoma: surgery or endoscopic papillectomy? Gastrointest Endosc. 2007;66:701-7. (Pubitemid 47464249)
15. Dixon E, Vollmer Jr CM, Sahajpal A, et al. Transduodenal resection of peri-ampullary lesions. World J Surg. 2005;29:649-52. (Pubitemid 41187408)
16. Hatzaras I, George N, Muscarella P, et al. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17:991-7.
17. Duffy JP, Hines OJ, Liu JH, et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. Arch Surg. 2003;138:941-8.
18. de Paiva Haddad LB, Patzina RA, et al. Lymph node involvement and not the histopathologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2010;14:719-28.
19. Qiao QL, Zhao YG, YeML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31:137-43.
20. Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010;14:379-87.
21. Riall TS, Cameron JL, Lillemoe KD, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140:764-72. (Pubitemid 44648193)
22. Roland CL, Katz MH, Gonzalez GM, et al. A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. J Gastrointest Surg. 2012;16:2056-63.
23. Sierzega M, Nowak K, Kulig J, et al. Lymph node involvement in ampullary cancer: the importance of the number, ratio, and location of metastatic nodes. J Surg Oncol. 2009;100(1):19-24.
24. Botsios D, Zacharakis E, Lambrou I, et al. Our local experience with the surgical treatment of ampullary cancer. Int Semin Surg Oncol. 2005;2:16.
25. Lee JH, Whittington R, Williams NN, et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys. 2000;47:945 -53.
26. Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999;134:526-32. (Pubitemid 29218124)
27. Hsu HP, Yang TM, Hsieh YH, et al. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol. 2007;14:50-60.
28. Zhou G, Chiu D, Qin D, et al. The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA. Mol Biotechnol. 2012;52:59-67.
29. Zhou G, Niu L, Chiu D, et al. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Biotechnol Lett. 2012;34:1235-41.
30. Zhou J, Hsu CC, Winter JM, et al. Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater. Radiother Oncol. 2009;92:244-8.
31. Narang AK, Miller RC, Hsu CC, et al. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol. 2011;6:126.